Koseido (02273) intends to further exercise the authorization to repurchase shares.

The Intelligent Financial News App reported that Gusuncare (02273) announced that, according to the resolution passed by the shareholders at the annual general meeting held on June 20, 2025, the directors of the company were granted a general authorization to repurchase up to 23.6965 million shares of the company, representing 10% of the total number of issued shares as of June 20, 2025 (repurchase authorization). On August 29, 2025, the board of directors decided to exercise the repurchase authorization and repurchase shares on the open market for a total price of up to 300 million Hong Kong dollars (previously proposed share repurchase). In addition to the previously proposed total price for the share repurchase, on November 6, 2025, the board of directors further decided to exercise the repurchase authorization and repurchase shares on the open market for an additional maximum of 300 million Hong Kong dollars (proposed share repurchase).